Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Wiedermann

Showing results (121-130 of 167) with videos related to

Pageof 17
Sort By:
Immunobiology|January 1, 1981
Comparison between human IgM and IgG antibodies to dextran, regarding their activities in antibody-dependent cellular cytotoxicity (ADCC)H Rumpold, D Kraft, O Scheiner, et al.
Immunobiology|June 1, 1989
Interaction of different strains of Entamoeba histolytica with target cells: characterization of electrophysiological and morphological featuresH Kollaritsch, J Graf, H Stemberger, et al.
Vaccine|August 1, 1997
Immunogenicity and protectivity of a new liposomal hepatitis A vaccineF Ambrosch, G Wiedermann, S Jonas, et al.
European Journal of Biochemistry|November 1, 1995
The basic isoform of profilin in pathogenic Entamoeba histolytica. cDNA cloning, heterologous expression, and actin-binding propertiesM Binder, S Ortner, H Erben, et al.
Vaccine|May 1, 1994
Combined vaccination against yellow fever and typhoid fever: a comparative trialF Ambrosch, B Fritzell, J Gregor, et al.
Zeitschrift Fur Immunitatsforschung, Experimentelle Und Klinische Immunologie|September 1, 1973
[Complement activation and endothelial damage in the first two hours after experimental kidney homotransplantation (author's transl)]M Kux, F Piza, R Rauhs, et al.
Transplantation|June 1, 1973
Immediate complement consumption and ultrastructural lesions in canine renal allograftsM Kux, F Piza, R Rauhs, et al.
The Journal of Infectious Diseases|April 1, 1997
Safety and immunogenicity of live oral cholera and typhoid vaccines administered alone or in combination with antimalarial drugs, oral polio vaccine, or yellow fever vaccineH Kollaritsch, J U Que, C Kunz, et al.
Wiener Klinische Wochenschrift|July 13, 2000
Mefloquine concentration profiles during prophylactic dose regimensH Kollaritsch, J Karbwang, G Wiedermann, et al.
Infection and Immunity|April 1, 1996
Randomized, double-blind placebo-controlled trial to evaluate the safety and immunogenicity of combined Salmonella typhi Ty21a and Vibrio cholerae CVD 103-HgR live oral vaccinesH Kollaritsch, E Furer, C Herzog, et al.
Pageof 17

Showing results (121-130 of 167) with videos related to

Sort By:
Pageof 17
Immunobiology|January 1, 1981
Comparison between human IgM and IgG antibodies to dextran, regarding their activities in antibody-dependent cellular cytotoxicity (ADCC)H Rumpold, D Kraft, O Scheiner, et al.
Immunobiology|June 1, 1989
Interaction of different strains of Entamoeba histolytica with target cells: characterization of electrophysiological and morphological featuresH Kollaritsch, J Graf, H Stemberger, et al.
Vaccine|August 1, 1997
Immunogenicity and protectivity of a new liposomal hepatitis A vaccineF Ambrosch, G Wiedermann, S Jonas, et al.
European Journal of Biochemistry|November 1, 1995
The basic isoform of profilin in pathogenic Entamoeba histolytica. cDNA cloning, heterologous expression, and actin-binding propertiesM Binder, S Ortner, H Erben, et al.
Vaccine|May 1, 1994
Combined vaccination against yellow fever and typhoid fever: a comparative trialF Ambrosch, B Fritzell, J Gregor, et al.
Zeitschrift Fur Immunitatsforschung, Experimentelle Und Klinische Immunologie|September 1, 1973
[Complement activation and endothelial damage in the first two hours after experimental kidney homotransplantation (author's transl)]M Kux, F Piza, R Rauhs, et al.
Transplantation|June 1, 1973
Immediate complement consumption and ultrastructural lesions in canine renal allograftsM Kux, F Piza, R Rauhs, et al.
The Journal of Infectious Diseases|April 1, 1997
Safety and immunogenicity of live oral cholera and typhoid vaccines administered alone or in combination with antimalarial drugs, oral polio vaccine, or yellow fever vaccineH Kollaritsch, J U Que, C Kunz, et al.
Wiener Klinische Wochenschrift|July 13, 2000
Mefloquine concentration profiles during prophylactic dose regimensH Kollaritsch, J Karbwang, G Wiedermann, et al.
Infection and Immunity|April 1, 1996
Randomized, double-blind placebo-controlled trial to evaluate the safety and immunogenicity of combined Salmonella typhi Ty21a and Vibrio cholerae CVD 103-HgR live oral vaccinesH Kollaritsch, E Furer, C Herzog, et al.
Pageof 17